https://scholars.lib.ntu.edu.tw/handle/123456789/402404
標題: | Antiobesity molecular mechanisms of action: Resveratrol and pterostilbene | 作者: | MIN-HSIUNG PAN Jia-Ching Wu Chi-Tang Ho Ching-Shu Lai |
關鍵字: | brown adipose tissue; obesity; pterostilbene; resveratrol; white adipose tissue | 公開日期: | 一月-2018 | 卷: | 44 | 期: | 1 | 起(迄)頁: | 50--60 | 來源出版物: | BioFactors | 摘要: | Obesity is a current global epidemic that has led to a marked increase in metabolic diseases. However, its treatment remains a challenge. Obesity is a multifactorial disease, which involves the dysfunction of neuropeptides, hormones, and inflammatory adipokines from the brain, gut, and adipose tissue. An understanding of the mechanisms and signal interactions in the crosstalk between organs and tissue in the coordination of whole-body energy metabolism would be helpful to provide therapeutic and putative approaches to the treatment and prevention of obesity and related complications. Resveratrol and pterostilbene are well-known stilbenes that provide various potential benefits to human health. In particular, their potential anti-obesity effects have been proven in numerous cell culture and animal studies. Both compounds act to regulate energy intake, adipocyte life cycle and function, white adipose tissue (WAT) inflammation, energy expenditure, and gut microbiota by targeting multiple molecules and signaling pathways as an intervention for obesity. Although the efficacy of both compounds in humans requires further investigation with respect to their oral bioavailability, promising scientific findings have highlighted their potential as candidates for the treatment of obesity and the improvement of obesity-related metabolic diseases. ? 2018 BioFactors, 44(1):50–60, 2018. ? 2018 International Union of Biochemistry and Molecular Biology |
URI: | https://doi.org/10.1002/biof.1409 http://scholars.lib.ntu.edu.tw/handle/123456789/402404 |
DOI: | 10.1002/biof.1409 | SDG/關鍵字: | pterostilbene; resveratrol; adipocytokine; antiobesity agent; pterostilbene; resveratrol; stilbene derivative; caloric intake; cell cycle; cell function; drug bioavailability; energy expenditure; food intake; human; inflammation; intestine flora; nonhuman; obesity; obesity management; priority journal; Review; signal transduction; thermogenesis; white adipocyte; white adipose tissue; adipocyte; animal; brown adipose tissue; diet therapy; drug effect; energy metabolism; gene expression; genetics; lipid diet; metabolism; obesity; pathology; Adipocytes; Adipokines; Adipose Tissue, Brown; Adipose Tissue, White; Animals; Anti-Obesity Agents; Diet, High-Fat; Energy Metabolism; Gastrointestinal Microbiome; Gene Expression; Humans; Obesity; Signal Transduction; Stilbenes; Thermogenesis |
顯示於: | 食品科技研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。